Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinoma. | Biomed Pharmacother | 2025 | 41202420 | PubTator, text mining | PubMed |
| AdaSemb: an adaptive knowledge-driven deep learning framework integrating cancer protein assemblies for predicting PI3Kα inhibitor response and resistance. | Brief Bioinform | 2025 | 41020523 | PubTator, text mining | PubMed |
| GTEx pro enables accurate multi-tissue gene expression analysis using robust normalization and batch correction. | Sci Rep | 2025 | 40987889 | PubTator, text mining | PubMed |
| PDK1, associated with glycolytic metabolism, is a potential prognostic biomarker in osteosarcoma. | PLoS One | 2025 | 40971960 | PubTator, text mining | PubMed |
| Targeting lysosomal protease CTSL promotes anti-tumor immunity and sensitizes HNSCC to PD-1 blockade by stabilizing PDK1 and activating Akt-PD-L1 axis. | Neoplasia | 2025 | 40961907 | PubTator, text mining | PubMed |
| Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease. | Transl Neurodegener | 2025 | 40847318 | PubTator, text mining | PubMed |
| Integrative spatial multi-omics identifies the TEK receptor tyrosine kinase as a central biomacromolecule of endothelial-immune interactions in glioblastoma. | Int J Biol Macromol | 2025 | 40834945 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of Wilms tumor. | Nat Commun | 2025 | 40830093 | PubTator, text mining | PubMed |
| Proteogenomic characterization of invasive breast tumors in young women. | NPJ Breast Cancer | 2025 | 40826002 | PubTator, text mining | PubMed |
| Synthesis, molecular docking, pharmacological evaluation, MD simulation, and DFT calculations of quinazolin-12-one derivatives as PDK1 inhibitors. | Nanoscale Adv | 2025 | 40808821 | PubTator, text mining | PubMed |
| Lasiokaurin suppresses breast cancer growth by blocking autophagic flux and regulating cellular energy homeostasis. | Biochem Pharmacol | 2025 | 40782951 | PubTator, text mining | PubMed |
| An Integrated Machine Learning Framework for Developing and Validating a Diagnostic Model of Hub Genes Related to Lipid Metabolism in Chronic Rhinosinusitis. | J Inflamm Res | 2025 | 40756419 | PubTator, text mining | PubMed |
| Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review. | Front Endocrinol (Lausanne) | 2025 | 40747301 | PubTator, text mining | PubMed |
| Bone marrow mesenchymal stem cell derived exosomal miR-361-5p reversed the effect of bortezomib on multiple myeloma. | Technol Health Care | 2025 | 40746215 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Deciphering Cuproptosis in Sepsis: Mechanisms, Consequences, and Therapeutic Opportunities. | J Inflamm Res | 2025 | 40735271 | PubTator, text mining | PubMed |
| Integrative multi-omics and bioinformatics analysis of the effects of BaiRui YuPingFeng Powder on intestinal health in broilers. | Front Vet Sci | 2025 | 40607343 | PubTator, text mining | PubMed |
| GraphAge: Unleashing the power of graph neural network to decode epigenetic aging. | PNAS Nexus | 2025 | 40583914 | PubTator, text mining | PubMed |
| Circ_0084927 promotes progression of intrahepatic cholangiocarcinoma by sponging miR-4725-5p to activate the PDPK1/AKT/mTOR signaling pathway. | Cell Signal | 2025 | 40581264 | PubTator, text mining | PubMed |
| Mechanistic role of miR-375 in regulating PDPK1 to promote progression of small bowel neuroendocrine tumors: a silico analysis. | Discov Oncol | 2025 | 40549235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=3